Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 176

1.

Exact sequential analysis for multiple weighted binomial end points.

Silva IR, Gagne JJ, Najafzadeh M, Kulldorff M.

Stat Med. 2019 Nov 25. doi: 10.1002/sim.8405. [Epub ahead of print]

PMID:
31769079
2.

Variation in Prescription Drug Prices by Retail Pharmacy Type: A National Cross-sectional Study.

Luo J, Kulldorff M, Sarpatwari A, Pawar A, Kesselheim AS.

Ann Intern Med. 2019 Oct 1. doi: 10.7326/M18-1138. [Epub ahead of print]

PMID:
31569218
3.

A primer on quantitative bias analysis with positive predictive values in research using electronic health data.

Newcomer SR, Xu S, Kulldorff M, Daley MF, Fireman B, Glanz JM.

J Am Med Inform Assoc. 2019 Dec 1;26(12):1664-1674. doi: 10.1093/jamia/ocz094.

PMID:
31365086
4.

Investigating Possible Infectious Causes of Chronic Kidney Disease of Unknown Etiology in a Nicaraguan Mining Community.

Yih WK, Kulldorff M, Friedman DJ, Leibler JH, Amador JJ, López-Pilarte D, Galloway RL, Ramírez-Rubio O, Riefkohl A, Brooks DR.

Am J Trop Med Hyg. 2019 Sep;101(3):676-683. doi: 10.4269/ajtmh.18-0856.

5.

Kawasaki disease and 13-valent pneumococcal conjugate vaccination among young children: A self-controlled risk interval and cohort study with null results.

Baker MA, Baer B, Kulldorff M, Zichittella L, Reindel R, DeLuccia S, Lipowicz H, Freitas K, Jin R, Yih WK.

PLoS Med. 2019 Jul 2;16(7):e1002844. doi: 10.1371/journal.pmed.1002844. eCollection 2019 Jul.

6.

Using the Self-Controlled Tree-Temporal Scan Statistic to Assess the Safety of Live Attenuated Herpes Zoster Vaccine.

Yih WK, Kulldorff M, Dashevsky I, Maro JC.

Am J Epidemiol. 2019 Jul 1;188(7):1383-1388. doi: 10.1093/aje/kwz104.

PMID:
31062840
7.

Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical Care.

Patorno E, Pawar A, Franklin JM, Najafzadeh M, Déruaz-Luyet A, Brodovicz KG, Sambevski S, Bessette LG, Santiago Ortiz AJ, Kulldorff M, Schneeweiss S.

Circulation. 2019 Jun 18;139(25):2822-2830. doi: 10.1161/CIRCULATIONAHA.118.039177. Epub 2019 Apr 8.

PMID:
30955357
8.

Cardiovascular safety of linagliptin compared with other oral glucose-lowering agents in patients with type 2 diabetes: A sequential monitoring programme in routine care.

Patorno E, Gopalakrishnan C, Brodovicz KG, Meyers A, Bartels DB, Liu J, Kulldorff M, Schneeweiss S.

Diabetes Obes Metab. 2019 Aug;21(8):1824-1836. doi: 10.1111/dom.13735. Epub 2019 May 1.

PMID:
30941884
9.

Sequential Monitoring of the Comparative Effectiveness and Safety of Dabigatran in Routine Care.

Schneeweiss S, Gopalakrishnan C, Bartels DB, Franklin JM, Zint K, Kulldorff M, Huybrechts KF.

Circ Cardiovasc Qual Outcomes. 2019 Feb;12(2):e005173. doi: 10.1161/CIRCOUTCOMES.118.005173.

PMID:
30764655
10.

Use of three summary measures of pediatric vaccination for studying the safety of the childhood immunization schedule.

Xu S, Newcomer SR, Kulldorff M, Daley MF, Fireman B, Glanz JM.

Vaccine. 2019 Feb 28;37(10):1325-1331. doi: 10.1016/j.vaccine.2019.01.040. Epub 2019 Jan 29.

PMID:
30709727
11.

Intraseason Waning of Influenza Vaccine Effectiveness.

Ray GT, Lewis N, Klein NP, Daley MF, Wang SV, Kulldorff M, Fireman B.

Clin Infect Dis. 2019 May 2;68(10):1623-1630. doi: 10.1093/cid/ciy770.

PMID:
30204855
12.

Data Mining for Adverse Drug Events With a Propensity Score-matched Tree-based Scan Statistic.

Wang SV, Maro JC, Baro E, Izem R, Dashevsky I, Rogers JR, Nguyen M, Gagne JJ, Patorno E, Huybrechts KF, Major JM, Zhou E, Reidy M, Cosgrove A, Schneeweiss S, Kulldorff M.

Epidemiology. 2018 Nov;29(6):895-903. doi: 10.1097/EDE.0000000000000907.

13.

Statistical Power for Postlicensure Medical Product Safety Data Mining.

Maro JC, Nguyen MD, Dashevsky I, Baker MA, Kulldorff M.

EGEMS (Wash DC). 2017 Jun 12;5(1):6. doi: 10.5334/egems.225.

14.

Assessment of Quadrivalent Human Papillomavirus Vaccine Safety Using the Self-Controlled Tree-Temporal Scan Statistic Signal-Detection Method in the Sentinel System.

Yih WK, Maro JC, Nguyen M, Baker MA, Balsbaugh C, Cole DV, Dashevsky I, Mba-Jonas A, Kulldorff M.

Am J Epidemiol. 2018 Jun 1;187(6):1269-1276. doi: 10.1093/aje/kwy023.

15.

Yih et al. Respond to "Moving From Evidence to Impact for Human Papillomavirus Vaccination".

Yih WK, Maro JC, Kulldorff M.

Am J Epidemiol. 2018 Jun 1;187(6):1281. doi: 10.1093/aje/kwy022. No abstract available.

PMID:
29860469
16.

Reuse of data sources to evaluate drug safety signals: When is it appropriate?

Wang SV, Kulldorff M, Glynn RJ, Gagne JJ, Pottegård A, Rothman KJ, Schneeweiss S, Walker AM.

Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):567-569. doi: 10.1002/pds.4442. Epub 2018 Apr 27. No abstract available.

PMID:
29701279
17.

Counter-Point: Early Warning Systems Are Imperfect, but Essential.

Lu CY, Simon G, Soumerai SB, Kulldorff M.

Med Care. 2018 May;56(5):382-383. doi: 10.1097/MLR.0000000000000896.

18.

Near Real-time Surveillance for Consequences of Health Policies Using Sequential Analysis.

Lu CY, Penfold RB, Toh S, Sturtevant JL, Madden JM, Simon G, Ahmedani BK, Clarke G, Coleman KJ, Copeland LA, Daida YG, Davis RL, Hunkeler EM, Owen-Smith A, Raebel MA, Rossom R, Soumerai SB, Kulldorff M.

Med Care. 2018 May;56(5):365-372. doi: 10.1097/MLR.0000000000000893.

19.

Border analysis for spatial clusters.

Oliveira FLP, Cançado ALF, de Souza G, Moreira GJP, Kulldorff M.

Int J Health Geogr. 2018 Feb 17;17(1):5. doi: 10.1186/s12942-018-0124-1.

20.

Meningococcal conjugate vaccine safety surveillance in the Vaccine Safety Datalink using a tree-temporal scan data mining method.

Li R, Weintraub E, McNeil MM, Kulldorff M, Lewis EM, Nelson J, Xu S, Qian L, Klein NP, Destefano F.

Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):391-397. doi: 10.1002/pds.4397. Epub 2018 Feb 15.

PMID:
29446176
21.

Methods for addressing "innocent bystanders" when evaluating safety of concomitant vaccines.

Wang SV, Abdurrob A, Spoendlin J, Lewis E, Newcomer SR, Fireman B, Daley MF, Glanz JM, Duffy J, Weintraub ES, Kulldorff M.

Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):405-412. doi: 10.1002/pds.4399. Epub 2018 Feb 13.

22.

Bias from outcome misclassification in immunization schedule safety research.

Newcomer SR, Kulldorff M, Xu S, Daley MF, Fireman B, Lewis E, Glanz JM.

Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):221-228. doi: 10.1002/pds.4374. Epub 2018 Jan 2.

23.

Study protocol for the dabigatran, apixaban, rivaroxaban, edoxaban, warfarin comparative effectiveness research study.

Krumme AA, Pawar A, Schneeweiss S, Glynn RJ, Choudhry NK, Kulldorff M, Ortiz AS, Avorn J, Gagne JJ.

J Comp Eff Res. 2018 Jan;7(1):57-66. doi: 10.2217/cer-2017-0053. Epub 2017 Dec 21.

PMID:
29264930
24.

A Bias in the Evaluation of Bias Comparing Randomized Trials with Nonexperimental Studies.

Franklin JM, Dejene S, Huybrechts KF, Wang SV, Kulldorff M, Rothman KJ.

Epidemiol Methods. 2017 Apr;6(1). pii: 20160018. doi: 10.1515/em-2016-0018. Epub 2017 Apr 22.

25.

Research Techniques Made Simple: An Introduction to Use and Analysis of Big Data in Dermatology.

Wehner MR, Levandoski KA, Kulldorff M, Asgari MM.

J Invest Dermatol. 2017 Aug;137(8):e153-e158. doi: 10.1016/j.jid.2017.04.019. Review.

26.

Geospatial analysis of nonmedical vaccine exemptions and pertussis outbreaks in the United States.

Aloe C, Kulldorff M, Bloom BR.

Proc Natl Acad Sci U S A. 2017 Jul 3;114(27):7101-7105. doi: 10.1073/pnas.1700240114. Epub 2017 Jun 20.

27.

Evaluation of optic neuritis following human papillomavirus vaccination.

Sridhar G, Tian F, Forshee R, Kulldorff M, Selvam N, Sutherland A, Bryan W, Barone S, Xu L, Izurieta HS.

Hum Vaccin Immunother. 2017 Jul 3;13(7):1705-1713. doi: 10.1080/21645515.2017.1310788. Epub 2017 May 2.

28.

Daily Reportable Disease Spatiotemporal Cluster Detection, New York City, New York, USA, 2014-2015.

Greene SK, Peterson ER, Kapell D, Fine AD, Kulldorff M.

Emerg Infect Dis. 2016 Oct;22(10):1808-12. doi: 10.3201/eid2210.160097.

29.

Statistical detection of geographic clusters of resistant Escherichia coli in a regional network with WHONET and SaTScan.

Park R, O'Brien TF, Huang SS, Baker MA, Yokoe DS, Kulldorff M, Barrett C, Swift J, Stelling J; Centers for Disease Control and Prevention Epicenters Program.

Expert Rev Anti Infect Ther. 2016 Nov;14(11):1097-1107. Epub 2016 Sep 6.

30.

Using Gini coefficient to determining optimal cluster reporting sizes for spatial scan statistics.

Han J, Zhu L, Kulldorff M, Hostovich S, Stinchcomb DG, Tatalovich Z, Lewis DR, Feuer EJ.

Int J Health Geogr. 2016 Aug 3;15(1):27. doi: 10.1186/s12942-016-0056-6.

31.

Geographic Clusters of Basal Cell Carcinoma in a Northern California Health Plan Population.

Ray GT, Kulldorff M, Asgari MM.

JAMA Dermatol. 2016 Nov 1;152(11):1218-1224. doi: 10.1001/jamadermatol.2016.2536.

32.

Local spatial clustering in youths' use of tobacco, alcohol, and marijuana in Boston.

Duncan DT, Rienti M Jr, Kulldorff M, Aldstadt J, Castro MC, Frounfelker R, Williams JH, Sorensen G, Johnson RM, Hemenway D, Williams DR.

Am J Drug Alcohol Abuse. 2016 Jul;42(4):412-21. doi: 10.3109/00952990.2016.1151522. Epub 2016 Apr 20.

33.

Public domain small-area cancer incidence data for New York State, 2005-2009.

Boscoe FP, Talbot TO, Kulldorff M.

Geospat Health. 2016 Apr 18;11(1):304. doi: 10.4081/gh.2016.304.

34.

Prospective influenza vaccine safety surveillance using fresh data in the Sentinel System.

Yih WK, Kulldorff M, Sandhu SK, Zichittella L, Maro JC, Cole DV, Jin R, Kawai AT, Baker MA, Liu C, McMahill-Walraven CN, Selvan MS, Platt R, Nguyen MD, Lee GM.

Pharmacoepidemiol Drug Saf. 2016 May;25(5):481-92. doi: 10.1002/pds.3908. Epub 2015 Nov 17.

35.

Evaluation of the risk of venous thromboembolism after quadrivalent human papillomavirus vaccination among US females.

Yih WK, Greene SK, Zichittella L, Kulldorff M, Baker MA, de Jong JL, Gil-Prieto R, Griffin MR, Jin R, Lin ND, McMahill-Walraven CN, Reidy M, Selvam N, Selvan MS, Nguyen MD.

Vaccine. 2016 Jan 2;34(1):172-8. doi: 10.1016/j.vaccine.2015.09.087. Epub 2015 Nov 6.

36.

Quantifying the impact of time-varying baseline risk adjustment in the self-controlled risk interval design.

Li L, Kulldorff M, Russek-Cohen E, Kawai AT, Hua W.

Pharmacoepidemiol Drug Saf. 2015 Dec;24(12):1304-12. doi: 10.1002/pds.3885. Epub 2015 Oct 13.

PMID:
26464236
37.

Febrile Seizures After 2010-2011 Trivalent Inactivated Influenza Vaccine.

Kawai AT, Martin D, Kulldorff M, Li L, Cole DV, McMahill-Walraven CN, Selvam N, Selvan MS, Lee GM.

Pediatrics. 2015 Oct;136(4):e848-55. doi: 10.1542/peds.2015-0635. Epub 2015 Sep 14.

38.

Continuous versus group sequential analysis for post-market drug and vaccine safety surveillance.

Silva IR, Kulldorff M.

Biometrics. 2015 Sep;71(3):851-8. doi: 10.1111/biom.12324. Epub 2015 May 22.

39.

Comments on 'a critical look at prospective surveillance using a scan statistic' by T. Correa, M. Costa, and R. Assunção.

Kulldorff M, Kleinman K.

Stat Med. 2015 Mar 30;34(7):1094-5. doi: 10.1002/sim.6430. No abstract available.

40.

Geographic clusters in underimmunization and vaccine refusal.

Lieu TA, Ray GT, Klein NP, Chung C, Kulldorff M.

Pediatrics. 2015 Feb;135(2):280-9. doi: 10.1542/peds.2014-2715. Epub 2015 Jan 19.

41.

Evaluation overview for the Massachusetts Childhood Obesity Research Demonstration (MA-CORD) project.

Davison KK, Falbe J, Taveras EM, Gortmaker S, Kulldorff M, Perkins M, Blaine RE, Franckle RL, Ganter C, Woo Baidal J, Kwass JA, Buszkiewicz J, Smith L, Land T; MA-CORD Study Group.

Child Obes. 2015 Feb;11(1):23-36. doi: 10.1089/chi.2014.0059. Epub 2015 Jan 9.

42.

Geographical Clusters of Rape in the United States: 2000-2012.

Amin R, Nabors NS, Nelson AM, Saqlain M, Kulldorff M.

Stat Public Policy (Phila). 2015;2(1):87-92. doi: 10.1080/2330443X.2015.1092899. Epub 2015 Sep 18.

43.

Maximum linkage space-time permutation scan statistics for disease outbreak detection.

Costa MA, Kulldorff M.

Int J Health Geogr. 2014 Jun 10;13:20. doi: 10.1186/1476-072X-13-20.

44.

Minimizing signal detection time in postmarket sequential analysis: balancing positive predictive value and sensitivity.

Maro JC, Brown JS, Dal Pan GJ, Kulldorff M.

Pharmacoepidemiol Drug Saf. 2014 Aug;23(8):839-48. doi: 10.1002/pds.3618. Epub 2014 Apr 3.

PMID:
24700557
45.

Relative risk estimates from spatial and space-time scan statistics: are they biased?

Prates MO, Kulldorff M, Assunção RM.

Stat Med. 2014 Jul 10;33(15):2634-44. doi: 10.1002/sim.6143. Epub 2014 Mar 18.

46.

Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barré syndrome, encephalitis, or anaphylaxis in the 2012-2013 season.

Kawai AT, Li L, Kulldorff M, Vellozzi C, Weintraub E, Baxter R, Belongia EA, Daley MF, Jacobsen SJ, Naleway A, Nordin JD, Lee GM.

Pharmacoepidemiol Drug Saf. 2014 May;23(5):548-53. doi: 10.1002/pds.3575. Epub 2014 Feb 4.

PMID:
24497128
47.

Intussusception risk after rotavirus vaccination in U.S. infants.

Yih WK, Lieu TA, Kulldorff M, Martin D, McMahill-Walraven CN, Platt R, Selvam N, Selvan M, Lee GM, Nguyen M.

N Engl J Med. 2014 Feb 6;370(6):503-12. doi: 10.1056/NEJMoa1303164. Epub 2014 Jan 14.

48.

Biochemical phenotypes to discriminate microbial subpopulations and improve outbreak detection.

Galar A, Kulldorff M, Rudnick W, O'Brien TF, Stelling J.

PLoS One. 2013 Dec 31;8(12):e84313. doi: 10.1371/journal.pone.0084313. eCollection 2013.

49.

Automated influenza-like illness reporting--an efficient adjunct to traditional sentinel surveillance.

Yih WK, Cocoros NM, Crockett M, Klompas M, Kruskal BA, Kulldorff M, Lazarus R, Madoff LC, Morrison MJ, Smole S, Platt R.

Public Health Rep. 2014 Jan-Feb;129(1):55-63.

50.

Laboratory-based prospective surveillance for community outbreaks of Shigella spp. in Argentina.

Viñas MR, Tuduri E, Galar A, Yih K, Pichel M, Stelling J, Brengi SP, Della Gaspera A, van der Ploeg C, Bruno S, Rogé A, Caffer MI, Kulldorff M, Galas M; Group MIDAS - Argentina.

PLoS Negl Trop Dis. 2013 Dec 12;7(12):e2521. doi: 10.1371/journal.pntd.0002521. eCollection 2013.

Supplemental Content

Loading ...
Support Center